APOE and Alzheimer disease: In this longitudinal multimodal biomarker study of individuals with a first‐degree family history of AD dementia spanning > 10 years, 27% developed MCI based on a multidisciplinary classification consensus meeting blind to AD biomarkers and APOE genotype information.